
Genetically engineered viruses that teach your immune system to kill cancer
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using technology developed at UCSF. The company is making the next Keytruda, a $25B/yr cancer drug blockbuster, starting with the most aggressive form of brain cancer, glioblastoma. In preclinical models, their approach improves survival rates from 0% with the FDA-approved standard-of-care treatment to greater than 90% long-term survival with our treatment.
Boutique Venture Partners backs authentic founders who transform industries and create new ones in healthcare and life sciences.